Renquan Lu

1.9k total citations
62 papers, 1.2k citations indexed

About

Renquan Lu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Renquan Lu has authored 62 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 26 papers in Oncology and 21 papers in Cancer Research. Recurrent topics in Renquan Lu's work include DNA Repair Mechanisms (9 papers), Pancreatic and Hepatic Oncology Research (7 papers) and Ovarian cancer diagnosis and treatment (6 papers). Renquan Lu is often cited by papers focused on DNA Repair Mechanisms (9 papers), Pancreatic and Hepatic Oncology Research (7 papers) and Ovarian cancer diagnosis and treatment (6 papers). Renquan Lu collaborates with scholars based in China, United States and India. Renquan Lu's co-authors include Lin Guo, Xiang Gao, Suhong Xie, Hui Zheng, Yanchun Wang, Ailing Zhong, Xianjun Yu, Jin Xu, Jiang Long and Guopei Luo and has published in prestigious journals such as Nature Communications, Blood and PLoS ONE.

In The Last Decade

Renquan Lu

59 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Renquan Lu China	21	625	405	343	196	130	62	1.2k
Federico Tozzi United States	11	714 1.1×	542 1.3×	428 1.2×	151 0.8×	193 1.5×	15	1.3k
Bo Gao Australia	19	984 1.6×	781 1.9×	280 0.8×	335 1.7×	149 1.1×	88	1.8k
Ai Sato Japan	16	630 1.0×	592 1.5×	352 1.0×	145 0.7×	162 1.2×	45	1.4k
Anna J. Żaczek Poland	23	693 1.1×	739 1.8×	528 1.5×	219 1.1×	61 0.5×	86	1.6k
Naz Chaudary Canada	22	695 1.1×	474 1.2×	522 1.5×	117 0.6×	108 0.8×	45	1.5k
Martin Schlesinger Germany	20	586 0.9×	590 1.5×	287 0.8×	157 0.8×	118 0.9×	40	1.4k
Liangfang Shen China	24	946 1.5×	390 1.0×	598 1.7×	202 1.0×	107 0.8×	77	1.5k
Tatsuhiro Yoshiki Japan	21	550 0.9×	246 0.6×	245 0.7×	314 1.6×	248 1.9×	68	1.3k
Dana M. Roque United States	20	348 0.6×	480 1.2×	134 0.4×	156 0.8×	123 0.9×	61	1.1k
Sherry J. Lim United States	12	564 0.9×	674 1.7×	343 1.0×	140 0.7×	244 1.9×	17	1.2k

Countries citing papers authored by Renquan Lu

Since Specialization

Citations

This map shows the geographic impact of Renquan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renquan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renquan Lu more than expected).

Fields of papers citing papers by Renquan Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renquan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renquan Lu. The network helps show where Renquan Lu may publish in the future.

Co-authorship network of co-authors of Renquan Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Renquan Lu. A scholar is included among the top collaborators of Renquan Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renquan Lu. Renquan Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xie, Congying, Yanchun Wang, Qingtian Li, et al.. (2025). The value of serum tumor-associated autoantibodies in screening and diagnosis of gastric cancer. Clinica Chimica Acta. 569. 120167–120167.

Lu, Renquan, Ying Wu, Yiwen Yao, et al.. (2025). TERC Stimulates Fatty Acid Metabolism to Promote Bladder Cancer Progression. Cancer Research. 85(19). 3689–3705.

Ma, Xiaolu, et al.. (2025). Stemness‐Relevant Gene Signature for Chemotherapeutic Response and Prognosis Prediction in Ovarian Cancer. Stem Cells International. 2025(1). 2505812–2505812. 1 indexed citations

Wang, Siyuan, Kaixiang Zhou, Wenjie Guo, et al.. (2024). Early detection of colorectal cancer using aberrant circulating cell-free mitochondrial DNA fragmentomics. Gut. 74(6). 961–970. 2 indexed citations

Meng, Xin, Hui Zheng, Xiaolu Ma, et al.. (2023). TPX2 promotes ovarian tumorigenesis by interacting with Lamin A/C and affecting its stability. Cancer Medicine. 12(8). 9738–9748. 5 indexed citations

Liu, Chen, Shengming Deng, Zhiwen Xiao, et al.. (2023). Glutamine is a substrate for glycosylation and CA19-9 biosynthesis through hexosamine biosynthetic pathway in pancreatic cancer. Discover Oncology. 14(1). 20–20. 6 indexed citations

Zheng, Hui, Xin Meng, Ying Tong, et al.. (2023). IFN-γ in ovarian tumor microenvironment upregulates HLA-E expression and predicts a poor prognosis. Journal of Ovarian Research. 16(1). 229–229. 6 indexed citations

Shang, Anquan, Zujun Sun, Wenjing Chang, et al.. (2022). Urinary Exosomal Long Noncoding RNA TERC as a Noninvasive Diagnostic and Prognostic Biomarker for Bladder Urothelial Carcinoma. Journal of Immunology Research. 2022. 1–9. 29 indexed citations

Li, Luying, Peipei Ding, Xinyue Lv, et al.. (2022). CD59-Regulated Ras Compartmentalization Orchestrates Antitumor T-cell Immunity. Cancer Immunology Research. 10(12). 1475–1489. 9 indexed citations

10.

Huang, Yan, et al.. (2021). GSG2 Promotes Development and Predicts Poor Prognosis of Ovarian Cancer. Cancer Management and Research. Volume 13. 499–508. 7 indexed citations

11.

Wang, Yanchun, Suhong Xie, Ying Tong, et al.. (2021). A Risk of Venous Thromboembolism Algorithm as a Predictor of Venous Thromboembolism in Patients with Colorectal Cancer. Clinical and Applied Thrombosis/Hemostasis. 27. 2975246404–2975246404. 3 indexed citations

12.

Zhu, Cheng, et al.. (2021). A combined strategy of TK1, HE4 and CA125 shows better diagnostic performance than risk of ovarian malignancy algorithm (ROMA) in ovarian carcinoma. Clinica Chimica Acta. 524. 43–50. 20 indexed citations

13.

Tang, Wei‐Guo, et al.. (2020). Serum STIP1, a Novel Indicator for Microvascular Invasion, Predicts Outcomes and Treatment Response in Hepatocellular Carcinoma. Frontiers in Oncology. 10. 511–511. 15 indexed citations

14.

Zhang, Guoliang, Renquan Lu, Man Wu, et al.. (2019). Colorectal cancer‐associated ~ 6 kDa hyaluronan serves as a novel biomarker for cancer progression and metastasis. FEBS Journal. 286(16). 3148–3163. 25 indexed citations

15.

Lu, Renquan, Suhong Xie, Yanchun Wang, et al.. (2019). MUS81 Participates in the Progression of Serous Ovarian Cancer Associated With Dysfunctional DNA Repair System. Frontiers in Oncology. 9. 1189–1189. 14 indexed citations

16.

Zhong, Ailing, Wenjun Qin, Jing Han, et al.. (2019). Diagnostic Significance of Serum IgG Galactosylation in CA19-9-Negative Pancreatic Carcinoma Patients. Frontiers in Oncology. 9. 114–114. 14 indexed citations

17.

Zhang, Hongqin, Guihong Zhang, Ailing Zhong, et al.. (2018). Targeting TPX2 suppresses proliferation and promotes apoptosis via repression of the PI3k/AKT/P21 signaling pathway and activation of p53 pathway in breast cancer. Biochemical and Biophysical Research Communications. 507(1-4). 74–82. 41 indexed citations

18.

Luo, Guopei, Chen Liu, Meng Guo, et al.. (2016). Potential Biomarkers in Lewis Negative Patients With Pancreatic Cancer. Annals of Surgery. 265(4). 800–805. 128 indexed citations

19.

Lu, Renquan. (2012). Egg white-mediated green synthesis of silver nanoparticles with excellent biocompatibility and enhanced radiation effects on cancer cells. International Journal of Nanomedicine. 7. 2101–2101. 97 indexed citations

20.

Lu, Renquan, Lin Guo, & Juan Hu. (2009). Studies on the value of human epididymis protein 4 in patients with ovarian cancer. Zhonghua jianyan yixue zazhi. 32(12). 1379–1383. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact